Liang Shi Overview

  • Primary Position
  • Director

Liang Shi General Information

Biography

Mr. Liang Shi served as Director at Sagamore Investments. Since joining the firm, Liang has been in charge of the direct investments and has provided advisory services to the investors, portfolio companies and other related parties. Liang was previously Senior Manager of Shanghai Pharmaceuticals Holding Co. Ltd where he was in charge of the M&A and direct investment group, where he managed and executed a number of M&A transactions, including the largest transaction in China's healthcare industry of more than US$ 500 million. Liang was also involved in the US$ 2.2 billion IPO of Shanghai Pharma in Hong Kong. Before that, Liang worked at Evonik Degussa, the largest fine chemical company in the world, as the M&A Manager in the Greater China region. Liang was born in China. He received a BA in International Finance and Trade from the University of Portsmouth and an MSc in Finance from the University of Bristol, U.K. Liang was born in China and is fluent in Mandarin and English.

Contact Information

Primary Position
Education
University of Bristol, MS (Master of Science)
University of Portsmouth, BA (Bachelor of Arts)
Gender
Male

Liang Shi FAQs

  • Who is Liang Shi?

    Mr. Liang Shi served as Director at Sagamore Investments.

  • How much does Liang Shi typically invest?

    Liang Shi's median deal size is .

  • What is Liang Shi’s main position?

    Liang Shi’s primary position is Director.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »